Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Gerretsen

Showing results (11-20 of 196) with videos related to

Pageof 20
Sort By:
Journal of Gambling Studies|December 22, 2019
Impaired Awareness of Problem and Pathological Gambling: A ReviewParita Shah, Lena Quilty, Julia Kim, et al.
Psychiatry Research|February 11, 2017
Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction studyPhilip Gerretsen, Hiroyoshi Takeuchi, Miracle Ozzoude, et al.
Dialogues in Clinical Neuroscience|February 9, 2010
The intersection of pharmacology, imaging, and genetics in the development of personalized medicinePhilip Gerretsen, Daniel J Müller, Arun Tiwari, et al.
Medical Hypotheses|June 30, 2015
Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophreniaFernando Caravaggio, Margaret Hahn, Shinichiro Nakajima, et al.
Current Alzheimer Research|March 12, 2019
Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case- Control StudiesEric E Brown, Parita Shah, Bruce G Pollock, et al.
Neuropsychologia|October 29, 2017
The neural correlates of apathy in schizophrenia: An exploratory investigationFernando Caravaggio, Gagan Fervaha, Mahesh Menon, et al.
Psychiatric Genetics|August 5, 2025
Effects of DNA methylation and polygenic scores on self-reported suicidal ideation in psychoses: no evidence of epigenetic basis of polygenic riskGeorge Nader, Matisse Ducharme, Philip Gerretsen, et al.
Biological Psychiatry|April 2, 2013
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass indexFernando Caravaggio, Sofia Raitsin, Philip Gerretsen, et al.
Journal of Alzheimer'S Disease : JAD|August 7, 2016
Tau in Late-Life Depression: A Systematic Review and Meta-AnalysisEric E Brown, Yusuke Iwata, Jun Ku Chung, et al.
Current Psychiatry Reports|April 29, 2010
Sensitivity to antipsychotic drugs in older adultsChloe Leon, Philip Gerretsen, Hiroyuki Uchida, et al.
Pageof 20

Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
Journal of Gambling Studies|December 22, 2019
Impaired Awareness of Problem and Pathological Gambling: A ReviewParita Shah, Lena Quilty, Julia Kim, et al.
Psychiatry Research|February 11, 2017
Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction studyPhilip Gerretsen, Hiroyoshi Takeuchi, Miracle Ozzoude, et al.
Dialogues in Clinical Neuroscience|February 9, 2010
The intersection of pharmacology, imaging, and genetics in the development of personalized medicinePhilip Gerretsen, Daniel J Müller, Arun Tiwari, et al.
Medical Hypotheses|June 30, 2015
Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophreniaFernando Caravaggio, Margaret Hahn, Shinichiro Nakajima, et al.
Current Alzheimer Research|March 12, 2019
Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case- Control StudiesEric E Brown, Parita Shah, Bruce G Pollock, et al.
Neuropsychologia|October 29, 2017
The neural correlates of apathy in schizophrenia: An exploratory investigationFernando Caravaggio, Gagan Fervaha, Mahesh Menon, et al.
Psychiatric Genetics|August 5, 2025
Effects of DNA methylation and polygenic scores on self-reported suicidal ideation in psychoses: no evidence of epigenetic basis of polygenic riskGeorge Nader, Matisse Ducharme, Philip Gerretsen, et al.
Biological Psychiatry|April 2, 2013
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass indexFernando Caravaggio, Sofia Raitsin, Philip Gerretsen, et al.
Journal of Alzheimer'S Disease : JAD|August 7, 2016
Tau in Late-Life Depression: A Systematic Review and Meta-AnalysisEric E Brown, Yusuke Iwata, Jun Ku Chung, et al.
Current Psychiatry Reports|April 29, 2010
Sensitivity to antipsychotic drugs in older adultsChloe Leon, Philip Gerretsen, Hiroyuki Uchida, et al.
Pageof 20